Cordis Corporation has announced the launch of its third-generation sirolimus-eluting coronary stent, Cypher Select Plus.

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1568, 2006-01, pp. : 23-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Abbott has announced the international launch of its everolimus-eluting coronary stent system [Xience V].

By  

Inpharma, Vol. 1, Iss. 1559, 2006-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

The Sirolimus-Eluting Stent: A Review of Its Use in the Treatment of Coronary Artery Disease

By McKeage K.   Murdoch D.   Goa K.L.  

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 3, 2003-01 ,pp. : 211-230

Adis International

Access to resources Recommend Favorite

Sirolimus-eluting stent reduces restenosis, coronary events

By  

Inpharma, Vol. 1, Iss. 1342, 2002-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Spotlight on the Sirolimus-Eluting Stent in Coronary Artery Disease

By McKeage K.   Murdoch D.   Goa K.L.  

American Journal of Drug Delivery, Vol. 2, Iss. 1, 2004-01 ,pp. : 69-73

Adis International

Access to resources Recommend Favorite

Sirolimus-eluting stent superior for coronary artery restenosis prevention

By  

Inpharma, Vol. 1, Iss. 1389, 2003-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite